Libor Minichbauer is heading pricing for Novartis Oncology Emerging Growth Markets unit. In his current role he is responsible for pricing and innovative pricing models in 80+ countries in Asia, Middle East, Africa and CIS. Libor has worked in the industry for the last 10 years, held various roles in development, health economics, and pricing. Prior to joining pharma, he has spent several years in consulting, and IT and finance industries. Libor obtained his MBA from DePaul University in Chicago. He also holds a Masters in International Trade and Diplomacy from the University of Economics in Prague and Masters in Pharmacoeconomics from Pompeu Fabra University in Barcelona.